These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 29890736)

  • 1. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
    Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.
    Gallegos KM; Drusano GL; D Argenio DZ; Brown AN
    J Infect Dis; 2016 Oct; 214(8):1192-7. PubMed ID: 27496974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
    Franco EJ; Pires de Mello CP; Brown AN
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
    Pires de Mello CP; Tao X; Kim TH; Bulitta JB; Rodriquez JL; Pomeroy JJ; Brown AN
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
    Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN
    Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
    Rattanaburee T; Junking M; Panya A; Sawasdee N; Songprakhon P; Suttitheptumrong A; Limjindaporn T; Haegeman G; Yenchitsomanus PT
    Antiviral Res; 2015 Dec; 124():83-92. PubMed ID: 26542647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
    Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC
    Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo.
    Chang J; Schul W; Butters TD; Yip A; Liu B; Goh A; Lakshminarayana SB; Alonzi D; Reinkensmeier G; Pan X; Qu X; Weidner JM; Wang L; Yu W; Borune N; Kinch MA; Rayahin JE; Moriarty R; Xu X; Shi PY; Guo JT; Block TM
    Antiviral Res; 2011 Jan; 89(1):26-34. PubMed ID: 21073903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses.
    Yu JS; Tseng CK; Lin CK; Hsu YC; Wu YH; Hsieh CL; Lee JC
    Antiviral Res; 2017 Jan; 137():49-57. PubMed ID: 27847245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing antiviral compounds in a dengue mouse model.
    Schul W; Yip A; Shi PY
    Methods Mol Biol; 2013; 1030():269-81. PubMed ID: 23821275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.
    Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
    Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of geraniin on dengue virus type-2 infected BALB/c mice.
    Abdul Ahmad SA; Palanisamy UD; Khoo JJ; Dhanoa A; Syed Hassan S
    Virol J; 2019 Feb; 16(1):26. PubMed ID: 30813954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
    Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
    Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3.
    Vigani AG; Gonçales ES; Pavan MH; Genari F; Tozzo R; Lazarini MS; Fais V; Feltrin A; Gonçales NS; Gonçales FL
    Braz J Infect Dis; 2012; 16(3):232-6. PubMed ID: 22729189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8.
    Tokumoto Y; Hiasa Y; Uesugi K; Watanabe T; Mashiba T; Abe M; Kumagi T; Ikeda Y; Matsuura B; Onji M
    J Infect Dis; 2012 Apr; 205(7):1121-30. PubMed ID: 22357660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors.
    Yeo KL; Chen YL; Xu HY; Dong H; Wang QY; Yokokawa F; Shi PY
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2086-93. PubMed ID: 25624323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection.
    Pawlotsky JM; Flisiak R; Sarin SK; Rasenack J; Piratvisuth T; Chuang WL; Peng CY; Foster GR; Shah S; Wedemeyer H; Hézode C; Zhang W; Wong KA; Li B; Avila C; Naoumov NV;
    Hepatology; 2015 Oct; 62(4):1013-23. PubMed ID: 26118427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
    Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
    Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antiviral activity of bromocriptine against dengue virus replication.
    Kato F; Ishida Y; Oishi S; Fujii N; Watanabe S; Vasudevan SG; Tajima S; Takasaki T; Suzuki Y; Ichiyama K; Yamamoto N; Yoshii K; Takashima I; Kobayashi T; Miura T; Igarashi T; Hishiki T
    Antiviral Res; 2016 Jul; 131():141-7. PubMed ID: 27181378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.